Evidence map›Paper›PMID 9050856›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Direct in vivo measurement of targeted binding in a human tumor xenograft.

D A Berk, F Yuan, M Leunig, R K Jain

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 143 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  8. Review
  9. Article
  10. Article
  11. Toward LocalizedIEEE transactions on magnetics · 2015
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Modeling tumor microenvironments in vitro.Journal of biomechanical engineering · 2014
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

D A BerkDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
F Yuan
M Leunig
R K Jain
University of Pennsylvania · USMassachusetts General Hospital · US

Funding

MOLECULAR MODIFICATIONS FOR IMPROVED DELIVERY IN TUMORSF32CA059255 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BERK, DAVID A · 1992 to 1994
–
PATHOPHYSIOLOGY OF EXPERIMENTAL AND HUMAN TUMORSR35CA056591 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 1993 to 1999
–
NCI NIH HHS CA-56591NCI NIH HHS CA-59255NCI NIH HHS F32 CA059255
6 · The paper itself

Abstract

Binding is crucial to the function of most biologically active molecules, but difficult to quantify directly in living tissue. To this end, fluorescence recovery after photobleaching was used to detect the immobilization of fluorescently labeled ligand caused by binding to receptors in vivo. Measurements of mAb affinity to target antigen within human tumor xenografts revealed a saturable binding isotherm, from which an in vivo carcinoembryonic antigen density of 0.56 nmol/g (5.0 x 10(5)/cell) and an association constant of Ka < or = 4 x 10(7) M(-1) were estimated. The present method can be adapted for in vivo studies of cell signaling, targeted drugs, gene therapy, and other processes involving receptor-ligand binding.

Indexed as

AnimalsAntibodies, MonoclonalAntigens, SurfaceBinding SitesCarcinoembryonic AntigenColonic NeoplasmsDiffusionFluoresceinFluoresceinsFluorescenceFluorescent DyesHumansImmunohistochemistryKineticsMiceMice, NudeAntibodies, MonoclonalAntigens, SurfaceCarcinoembryonic AntigenFluoresceinFluoresceinsFluorescent Dyesmonoclonal antibody ZCE 025

Identifiers

PMID9050856
PMCPMC19994
OpenAlexW2137561946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.